ODDB.org: Open Drug Database

Janssen-Cilag AG - Invokana 300 mg, Filmtabletten

Swissmedic Registration	62956	Sequence	02
Product name	Invokana 300 mg	Description	Filmtabletten
ATC-Classification	A10BK02	ATC-Description	Canagliflozin
Introduction of Sequence	29.01.2014

Composition

canagliflozinum 300 mg ut canagliflozinum hemihydricum, cellulosum microcristallinum, lactosum 117.78 mg, carmellosum natricum conexum corresp. natrium 2.52 mg, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Canagliflozinum	300 mg

BAG: Active Agent	Dose
Canagliflozinum	300 mg

Inactive agents	Dose	additional_information
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
E 171		color.
Hydroxypropylcellulosum
Lactosum	117.78 mg
Macrogol	3350
Magnesii Stearas
Poly(Alcohol Vinylicus)		Überzug
Pro Compresso Obducto
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
006	30 Tablet(s)	53.88	75.00	B	SL	Yes
008	100 Tablet(s)	179.58	211.70	B	SL	Yes

2025	©ywesee GmbH